The roll out of China’s expanded centralized procurement scheme is underway, including over two dozen provinces and some of the largest pharma markets in China, and involving huge volumes of products.
In a notice posted on its website, the Shanghai Procurement Administration, the general coordinator of the original “4+7” pilot scheme,...




![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)

